Literature DB >> 8949259

Imaging as a tool in exploring the neurodevelopment and genetics of schizophrenia.

S Frangou1, R M Murray.   

Abstract

Neuroimaging has enabled us to address questions about the timing and origin of brain abnormalities in schizophrenia. First episode and longitudinal computed tomography (CT) and magnetic resonance imaging (MRI) studies of schizophrenic patients have shown that the brain abnormalities are present at onset of psychosis and are non-progressive. Such findings support the idea that schizophrenia is a developmental rather than a degenerative condition. Furthermore, the presence of ventriculomegaly and diminished hemispheric asymmetry in familial schizophrenics and in those of their relatives who appear to be transmitting the disorder, implies involvement of the genes controlling neurodevelopment. However, genetic factors do not fully account for the development of schizophrenia; early environmental insults such as obstetric complications are also important and may interact with genetic predisposition. Brain development continues postnatally and profound maturational events also occur in adolescence and early adulthood. Magnetic resonance spectroscopy (MRS) studies allow the investigation of the developmental biochemistry of the living brain and are being used to explore the role of maturational brain events in determining the onset of psychosis.

Entities:  

Mesh:

Year:  1996        PMID: 8949259     DOI: 10.1093/oxfordjournals.bmb.a011569

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  8 in total

1.  Amygdala-hippocampal shape differences in schizophrenia: the application of 3D shape models to volumetric MR data.

Authors:  Martha E Shenton; Guido Gerig; Robert W McCarley; Gábor Székely; Ron Kikinis
Journal:  Psychiatry Res       Date:  2002-08-20       Impact factor: 3.222

Review 2.  When cortical development goes wrong: schizophrenia as a neurodevelopmental disease of microcircuits.

Authors:  Laurence Garey
Journal:  J Anat       Date:  2010-10       Impact factor: 2.610

3.  Paliperidone regulates intracellular redox system in rat brain: Role of purine mechanism.

Authors:  Kadir Demirci; Ramazan Özçankaya; H Ramazan Yilmaz; Ayşe Yiğit; Abdülhadi Cihangir Uğuz; Kadir Karakuş; Arif Demirdaş; Abdullah Akpınar
Journal:  Redox Rep       Date:  2014-12-29       Impact factor: 4.412

4.  Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide(25-35), N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death.

Authors:  Ming-Chang Yang; For-Wey Lung
Journal:  Psychopharmacology (Berl)       Date:  2011-04-27       Impact factor: 4.530

5.  Enhancement of executive functioning skills: an additional tier in the treatment of schizophrenia.

Authors:  Deana B Davalos; Mack Green; Daniel Rial
Journal:  Community Ment Health J       Date:  2002-10

6.  A selective review of multimodal fusion methods in schizophrenia.

Authors:  Jing Sui; Qingbao Yu; Hao He; Godfrey D Pearlson; Vince D Calhoun
Journal:  Front Hum Neurosci       Date:  2012-02-24       Impact factor: 3.169

Review 7.  Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.

Authors:  D Rice; S Barone
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

8.  Alterations of white matter integrity related to the season of birth in schizophrenia: a DTI study.

Authors:  Stéphanie Giezendanner; Sebastian Walther; Nadja Razavi; Claudia Van Swam; Melanie Sarah Fisler; Leila Maria Soravia; Jennifer Andreotti; Simon Schwab; Kay Jann; Roland Wiest; Helge Horn; Thomas Jörg Müller; Thomas Dierks; Andrea Federspiel
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.